“Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events - 04/09/15

Doi : 10.1016/j.jaci.2015.06.009

Keiichi Yamanaka, MD, PhD , Hitoshi Mizutani, MD
Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Japan

Le texte complet de cet article est disponible en PDF.

The Ministry of Education, Culture, Sports, Science, and Technology, Japan, provided grants for scientific research to K.Y. (grant no. 26461690) and H.M. (grant no. 24591647). K.Y. also received a grant from the Mie University Hospital Seed Grant Program 2014.

Disclosure of potential conflict of interest: K. Yamanaka has been supported by grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Mie University Hospital Seed Grant program (2014); research grants from Kyowa Hakko Kirin Co Ltd, Japan, Janssen Pharmaceutical KK, Japan, MSD Pharmaceuticals, Japan, and Mitsubishi Tanabe Pharma Corporation, Japan; and has received lecture fees from Kyowa Hakko Kirin Co Ltd, Janssen Pharmaceutical KK, Mitsubishi Tanabe Pharma Corporation, Maruho Co Ltd, Japan, AbbVie Pharmaceuticals, Japan, Novartis Pharma KK, Japan, GlaxoSmithKline Pharmaceuticals, Japan, and Torii Pharmaceutical Co Ltd. H. Mizutani has been supported by grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a grant from the Mie University Hospital Seed Grant program (2014); is a patent coholder for caspase-1 Tg mouse with Taiho Pharmaceutical Co Ltd, Japan; and has a royalty contract for caspase-1 Tg mouse with Oriental Yeast Co Ltd, Japan; has received research support from Kyowa Hakko Kirin Co Ltd, Janssen Pharmaceutical KK, MSD Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Eizai Co Ltd, Japan, POLA Pharma, Japan, and Kinoshokuhinkenkyusho Co Ltd; and has received lecture fees from Kyowa Hakko Kirin Co Ltd, Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical KK, Maruho Co Ltd, GSK, Japan, Eizai Co Ltd, Taisho Toyama Pharm, Japan, and POLA Pharma.